Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA‑21‑mediated PTEN/AKT/mTOR pathway

Sun,Tianyu; Duan,Liying; Li,Jiaju; Guo,Hongyu; Xiong,Mingyue

doi:10.3892/ijmm.2021.4979

Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA‑21‑mediated PTEN/AKT/mTOR pathway

Authors:
- Tianyu Sun
- Liying Duan
- Jiaju Li
- Hongyu Guo
- Mingyue Xiong
View Affiliations

Affiliations: Department of Traumatology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China, Department of Basic Medicine, Puyang Medical College, Puyang, Henan 457000, P.R. China
Published online on: June 4, 2021 https://doi.org/10.3892/ijmm.2021.4979
Article Number: 146
Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gypenoside XVII (GP‑17), one of the dominant active components of Gynostemma pentaphyllum, has been studied extensively and found to have a variety of pharmacological effects, including neuroprotective properties. However, the neuroprotective effects of GP‑17 against spinal cord injury (SCI), as well as its underlying mechanisms of action remain unknown. The present study aimed to investigate the effects of GP‑17 on motor recovery and histopathological changes following SCI and to elucidate the mechanisms underlying its neuroprotective effects in a mouse model of SCI. Motor recovery was evaluated using the Basso, Beattie and Bresnahan (BBB) locomotor rating scale. Spinal cord edema was detected by the wet/dry weight method. H&E staining was performed to examine the effect of GP‑17 on spinal cord damage. Inflammatory response production was assessed by ELISA. Candidate miRNAs were identified following the integrated analysis of the Gene Expression Omnibus (GEO) dataset GSE67515. Western blot analysis was also performed to detect the expression levels of associated proteins. The results revealed that GP‑17 treatment improved functional recovery, and suppressed neuronal apoptosis and the inflammatory response in the mouse model of SCI. Moreover, it was observed that miR‑21 expression was downregulated following SCI, whereas it was upregulated following the administration of GP‑17. The inhibition of miR‑21 eliminated the protective effects of GP‑17 on SCI‑induced neuronal apoptosis and the inflammatory response. In addition, phosphatase and tensin homologue (PTEN), a key molecule in the activation of the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway, was identified as a target of miR‑21, and PTEN expression was downregulated by GP‑17 through miR‑21. Furthermore, the PTEN/AKT/mTOR pathway was inactivated by SCI, whereas it was re‑activated by GP‑17 through the regulation of miR‑21 in mice with SCI. On the whole, the findings of the present study suggest that GP‑17 plays a protective role in SCI via regulating the miR‑21/PTEN/AKT/mTOR pathway.

View Figures

View References

1	Sekhon LH and Fehlings MG: Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976). 26(Suppl 24): S2–S12. 2001. View Article : Google Scholar
2	Goldshmit Y, Kanner S, Zacs M, Frisca F, Pinto AR, Currie PD and Pinkas-Kramarski R: Rapamycin increases neuronal survival, reduces inflammation and astrocyte proliferation after spinal cord injury. Mol Cell Neurosci. 68:82–91. 2015. View Article : Google Scholar : PubMed/NCBI
3	Blight AR: Delayed demyelination and macrophage invasion: A candidate for secondary cell damage in spinal cord injury. Cent Nerv Syst Trauma. 2:299–315. 1985. View Article : Google Scholar : PubMed/NCBI
4	Orr MB and Gensel JC: Spinal cord injury scarring and inflammation: Therapies targeting glial and inflammatory responses. Neurotherapeutics. 15:541–553. 2018. View Article : Google Scholar : PubMed/NCBI
5	Celik EC, Erhan B, Gunduz B and Lakse E: The effect of low-frequency TENS in the treatment of neuropathic pain in patients with spinal cord injury. Spinal Cord. 51:334–337. 2013. View Article : Google Scholar : PubMed/NCBI
6	Shen L and Ji HF: The pharmacology of curcumin: Is it the degradation products? Trends Mol Med. 18:138–144. 2012. View Article : Google Scholar : PubMed/NCBI
7	Jin W, Wang J, Zhu T, Yuan B, Ni H, Jiang J, Wang H and Liang W: Anti-inflammatory effects of curcumin in experimental spinal cord injury in rats. Inflamm Res. 63:381–387. 2014. View Article : Google Scholar : PubMed/NCBI
8	Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Kocak A, Yologlu S and Turkoz Y: Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury. Acta Pharmacol Sin. 27:1317–1325. 2006. View Article : Google Scholar : PubMed/NCBI
9	Zhou XM, Zhou ML, Zhang XS, Zhuang Z, Li T, Shi JX and Zhang X: Resveratrol prevents neuronal apoptosis in an early brain injury model. J Surg Res. 189:159–165. 2014. View Article : Google Scholar : PubMed/NCBI
10	Meng X, Wang M, Sun G, Ye J, Zhou Y, Dong X, Wang T, Lu S and Sun X: Attenuation of Aβ25-35-induced parallel autophagic and apoptotic cell death by gypenoside XVII through the estrogen receptor-dependent activation of Nrf2/ARE pathways. Toxicol Appl Pharmacol. 279:63–75. 2014. View Article : Google Scholar : PubMed/NCBI
11	Cui CH, Kim DJ, Jung SC, Kim SC and Im WT: Enhanced production of gypenoside LXXV using a novel ginsenoside-transforming β-glucosidase from ginseng-cultivating soil bacteria and its anti-cancer property. Molecules. 22:8442017. View Article : Google Scholar
12	Wan ZH and Zhao Q: Gypenoside inhibits interleukin-1β-induced inflammatory response in human osteoarthritis chondrocytes. J Biochem Mol Toxicol. 31:2017. View Article : Google Scholar
13	Meng X, Luo Y, Liang T, Wang M, Zhao J, Sun G and Sun X: Gypenoside XVII enhances lysosome biogenesis and autophagy flux and accelerates autophagic clearance of Amyloid-β through TFEB activation. J Alzheimers Dis. 52:1135–1150. 2016. View Article : Google Scholar : PubMed/NCBI
14	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
15	Liu NK, Wang XF, Lu QB and Xu XM: Altered microRNA expression following traumatic spinal cord injury. Exp Neurol. 219:424–429. 2009. View Article : Google Scholar : PubMed/NCBI
16	Liu G, Keeler BE, Zhukareva V and Houle JD: Cycling exercise affects the expression of apoptosis-associated microRNAs after spinal cord injury in rats. Exp Neurol. 226:200–206. 2010. View Article : Google Scholar : PubMed/NCBI
17	Dai J, Xu LJ, Han GD, Sun HL, Zhu GT, Jiang HT, Yu GY and Tang XM: MiR-137 attenuates spinal cord injury by modulating NEUROD4 through reducing inflammation and oxidative stress. Eur Rev Med Pharmacol Sci. 22:1884–1890. 2018.PubMed/NCBI
18	Lin CA, Duan KY, Wang XW and Zhang ZS: MicroRNA-409 promotes recovery of spinal cord injury by regulating ZNF366. Eur Rev Med Pharmacol Sci. 22:3649–3655. 2018.PubMed/NCBI
19	Feng JS, Sun JD, Wang XD, Fu CH, Gan LL and Ma R: MicroRNA-204-5p targets SOX11 to regulate the inflammatory response in spinal cord injury. Eur Rev Med Pharmacol Sci. 23:4089–4096. 2019.PubMed/NCBI
20	Yi LT, Mu RH, Dong SQ, Wang SS, Li CF, Geng D and Liu Q: MiR-124 antagonizes the antidepressant-like effects of standardized gypenosides in mice. J Psychopharmacol. 32:458–468. 2018. View Article : Google Scholar : PubMed/NCBI
21	Zu ML, Piao XL, Gao JM, Xing SF and Liu LH: Monomer gypenoside LI from Gynostemma pentaphyllum inhibits cell proliferation and upregulates expression of miR-128-3p in melanoma cells. J Biochem Mol Toxicol. 34:e224602020. View Article : Google Scholar : PubMed/NCBI
22	Lu KW, Ma YS, Yu FS, Huang YP, Chu YL, Wu RS, Liao CL, Chueh FS and Chung JG: Gypenosides induce cell death and alter gene expression in human oral cancer HSC-3 cells. Exp Ther Med. 14:2469–2476. 2017. View Article : Google Scholar : PubMed/NCBI
23	Zhang D, Xuan J, Zheng BB, Zhou YL, Lin Y, Wu YS, Zhou YF, Huang YX, Wang Q, Shen LY, et al: Metformin improves functional recovery after spinal cord injury via autophagy flux stimulation. Mol Neurobiol. 54:3327–3341. 2017. View Article : Google Scholar
24	Lilley E, Andrews MR, Bradbury EJ, Elliott H, Hawkins P, Ichiyama RM, Keeley J, Michael-Titus AT, Moon LDF, Pluchino S, et al: Refining rodent models of spinal cord injury. Exp Neurol. 328:1132732020. View Article : Google Scholar : PubMed/NCBI
25	Basso DM, Beattie MS and Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 12:1–21. 1995. View Article : Google Scholar : PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
27	Zhang T, Ni S, Luo Z, Lang Y, Hu J and Lu H: The protective effect of microRNA-21 in neurons after spinal cord injury. Spinal Cord. 57:141–149. 2019. View Article : Google Scholar :
28	Zhou J, Shuang O, Li J, Cai Z, Wu C and Wang W: MiR-34a alleviates spinal cord injury via TLR4 signaling by inhibiting HMGB-1. Exp Ther Med. 17:1912–1918. 2019.PubMed/NCBI
29	Yu X, Zhang S, Zhao D, Zhang X, Xia C, Wang T, Zhang M, Liu T, Huang W and Wu B: SIRT1 inhibits apoptosis in in vivo and in vitro models of spinal cord injury via microRNA-494. Int J Mol Med. 43:1758–1768. 2019.PubMed/NCBI
30	Zhao CL, Cui HA and Zhang XR: MiR-543-5p inhibits inflammation and promotes nerve regeneration through inactivation of the NF-κB in rats after spinal cord injury. Eur Rev Med Pharmacol Sci. 23(Suppl 3): S39–S46. 2019.
31	Wang T, Yuan W, Liu Y, Zhang Y, Wang Z, Chen X, Feng S, Xiu Y and Li W: MiR-142-3p is a potential therapeutic target for sensory function recovery of spinal cord injury. Med Sci Monit. 21:2553–2556. 2015. View Article : Google Scholar : PubMed/NCBI
32	Yi J, Wang D, Niu X, Hu J, Zhou Y and Li Z: MicroRNA-155 deficiency suppresses Th17 cell differentiation and improves locomotor recovery after spinal cord injury. Scand J Immunol. 81:284–290. 2015. View Article : Google Scholar : PubMed/NCBI
33	Tang J, Guo WC, Hu JF and Yu L: Let-7 participates in the regulation of inflammatory response in spinal cord injury through PI3K/Akt signaling pathway. Eur Rev Med Pharmacol Sci. 23:6767–6773. 2019.PubMed/NCBI
34	Hu JZ, Huang JH, Zeng L, Wang G, Cao M and Lu HB: Anti-apoptotic effect of microRNA-21 after contusion spinal cord injury in rats. J Neurotrauma. 30:1349–1360. 2013. View Article : Google Scholar : PubMed/NCBI
35	Xie W, Yang SY, Zhang Q, Zhou Y, Wang Y, Liu R, Wang W, Shi J, Ning B and Jia T: Knockdown of MicroRNA-21 promotes neurological recovery after acute spinal cord injury. Neurochem Res. 43:1641–1649. 2018. View Article : Google Scholar : PubMed/NCBI
36	Gutilla EA, Buyukozturk MM and Steward O: Long-term consequences of conditional genetic deletion of PTEN in the sensorimotor cortex of neonatal mice. Exp Neurol. 279:27–39. 2016. View Article : Google Scholar : PubMed/NCBI
37	Li Y, Guo Y, Fan Y, Tian H, Li K and Mei X: Melatonin enhances autophagy and reduces apoptosis to promote locomotor recovery in spinal cord injury via the PI3K/AKT/mTOR signaling pathway. Neurochem Res. 44:2007–2019. 2019. View Article : Google Scholar : PubMed/NCBI
38	Li W, Yao S, Li H, Meng Z and Sun X: Curcumin promotes functional recovery and inhibits neuronal apoptosis after spinal cord injury through the modulation of autophagy. J Spinal Cord Med. 44:37–45. 2021. View Article : Google Scholar :
39	Lee JY, Choi HY, Ju BG and Yune TY: Estrogen alleviates neuropathic pain induced after spinal cord injury by inhibiting microglia and astrocyte activation. Biochim Biophys Acta Mol Basis Dis. 1864:2472–2480. 2018. View Article : Google Scholar : PubMed/NCBI
40	Kachadroka S, Hall AM, Niedzielko TL, Chongthammakun S and Floyd CL: Effect of endogenous androgens on 17beta-estradiol-mediated protection after spinal cord injury in male rats. J Neurotrauma. 27:611–626. 2010. View Article : Google Scholar :
41	Samantaray S, Das A, Matzelle DC, Yu SP, Wei L, Varma A, Ray SK and Banik NL: Administration of low dose estrogen attenuates gliosis and protects neurons in acute spinal cord injury in rats. J Neurochem. 136:1064–1073. 2016. View Article : Google Scholar
42	Sribnick EA, Wingrave JM, Matzelle DD, Wilford GG, Ray SK and Banik NL: Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J Neurosci Res. 82:283–293. 2005. View Article : Google Scholar : PubMed/NCBI
43	Hayta E and Elden H: Acute spinal cord injury: A review of pathophysiology and potential of non-steroidal anti-inflammatory drugs for pharmacological intervention. J Chem Neuroanat. 87:25–31. 2018. View Article : Google Scholar
44	Zhu H, Xie R, Liu X, Shou J, Gu W, Gu S and Che X: MicroRNA-494 improves functional recovery and inhibits apoptosis by modulating PTEN/AKT/mTOR pathway in rats after spinal cord injury. Biomed Pharmacother. 92:879–887. 2017. View Article : Google Scholar : PubMed/NCBI
45	Jian YP, Dong SJ, Xu SS, Fan J, Liu WJ, Shao XW, Li T, Zhao SH and Wang YG: MicroRNA-34a suppresses neuronal apoptosis and alleviates microglia inflammation by negatively targeting the Notch pathway in spinal cord injury. Eur Rev Med Pharmacol Sci. 24:1420–1427. 2020.PubMed/NCBI
46	Xu Z, Zhang K, Wang Q and Zheng Y: MicroRNA124 improves functional recovery and suppresses Bax-dependent apoptosis in rats following spinal cord injury. Mol Med Rep. 19:2551–2560. 2019.PubMed/NCBI
47	Liu R, Wang W, Wang S, Xie W, Li H and Ning B: MicroRNA-21 regulates astrocytic reaction post-acute phase of spinal cord injury through modulating TGF-β signaling. Aging (Albany NY). 10:1474–1488. 2018. View Article : Google Scholar
48	Bhalala OG, Pan L, Sahni V, McGuire TL, Gruner K, Tourtellotte WG and Kessler JA: MicroRNA-21 regulates astrocytic response following spinal cord injury. J Neurosci. 32:17935–17947. 2012. View Article : Google Scholar : PubMed/NCBI
49	Huang JH, Cao Y, Zeng L, Wang G, Cao M, Lu HB and Hu JZ: Tetramethylpyrazine enhances functional recovery after contusion spinal cord injury by modulation of MicroRNA-21, FasL, PDCD4 and PTEN expression. Brain Res. 1648:35–45. 2016. View Article : Google Scholar : PubMed/NCBI
50	Jiang JJ, Liu CM, Zhang BY, Wang XW, Zhang M, Saijilafu, Zhang SR, Hall P, Hu YW and Zhou FQ: MicroRNA-26a supports mammalian axon regeneration in vivo by suppressing GSK3beta expression. Cell Death Dis. 6:e18652015. View Article : Google Scholar
51	Strickland ER, Hook MA, Balaraman S, Huie JR, Grau JW and Miranda RC: MicroRNA dysregulation following spinal cord contusion: Implications for neural plasticity and repair. Neuroscience. 186:146–160. 2011. View Article : Google Scholar : PubMed/NCBI
52	Montalban E, Mattugini N, Ciarapica R, Provenzano C, Savino M, Scagnoli F, Prosperini G, Carissimi C, Fulci V, Matrone C, et al: MiR-21 is an Ngf-modulated microRNA that supports Ngf signaling and regulates neuronal degeneration in PC12 cells. Neuromolecular Med. 16:415–430. 2014. View Article : Google Scholar : PubMed/NCBI
53	Strickland IT, Richards L, Holmes FE, Wynick D, Uney JB and Wong LF: Axotomy-induced miR-21 promotes axon growth in adult dorsal root ganglion neurons. PLoS One. 6:e234232011. View Article : Google Scholar : PubMed/NCBI
54	Liu NK and Xu XM: Neuroprotection and its molecular mechanism following spinal cord injury. Neural Regen Res. 7:2051–2062. 2012.PubMed/NCBI
55	Lewandowski G and Steward O: AAVshRNA-mediated suppression of PTEN in adult rats in combination with salmon fibrin administration enables regenerative growth of corticospinal axons and enhances recovery of voluntary motor function after cervical spinal cord injury. J Neurosci. 34:9951–9962. 2014. View Article : Google Scholar : PubMed/NCBI
56	Liu K, Lu Y, Lee JK, Samara R, Willenberg R, Sears-Kraxberger I, Tedeschi A, Park KK, Jin D, Cai B, et al: PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat Neurosci. 13:1075–1081. 2010. View Article : Google Scholar : PubMed/NCBI
57	Zhou H, Li X, Wu Q, Li F, Fu Z, Liu C, Liang Z, Chu T, Wang T, Lu L, et al: shRNA against PTEN promotes neurite outgrowth of cortical neurons and functional recovery in spinal cord contusion rats. Regen Med. 10:411–429. 2015. View Article : Google Scholar
58	Li X, Dai Y and Xu J: MiR-21 promotes pterygium cell proliferation through the PTEN/AKT pathway. Mol Vis. 24:485–494. 2018.
59	Liu HY, Zhang YY, Zhu BL, Feng FZ, Yan H, Zhang HY and Zhou B: MiR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT. Eur Rev Med Pharmacol Sci. 23:4149–4155. 2019.PubMed/NCBI
60	Qin S, Wang H, Liu G, Mei H and Chen M: MiR215p ameliorates hyperoxic acute lung injury and decreases apoptosis of AEC II cells via PTEN/AKT signaling in rats. Mol Med Rep. 20:4953–4962. 2019.PubMed/NCBI
61	Lv X, Liang J and Wang Z: MiR-21-5p reduces apoptosis and inflammation in rats with spinal cord injury through PI3K/AKT pathway. Panminerva Med. Jul 27–2020.